NEVIRAPINE APOTEX nevirapine 200 mg tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

nevirapine, Quantity: 200 mg

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

Nevirapine

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: magnesium stearate; lactose; microcrystalline cellulose; crospovidone; copovidone

Vía de administración:

Oral

Unidades en paquete:

60

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Nevirapine immediate-release tablets in combination with antiretroviral agents are indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Resumen del producto:

Visual Identification: white, oval shaped scored biconvex tablets with engraved "APO" and bisect on one side and "NAV" bisect "200" on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2016-03-17